Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
In Wiskott-Aldrich syndrome, platelet count matters.
Notarangelo LD.
Blood. 2013 Feb 28;121(9):1484-5. doi: 10.1182/blood-2013-01-475913.
Related citations
Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
Loyola Presa JG, de Carvalho VO, Morrisey LR, Bonfim CM, Abagge KT, Vasselai A, Marinoni LP.
Arch Dis Child. 2013 Apr;98(4):304-7. doi: 10.1136/archdischild-2011-300812. Epub 2013 Jan 23.
Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Prete F, Catucci M, Labrada M, Gobessi S, Castiello MC, Bonomi E, Aiuti A, Vermi W, Cancrini C, Metin A, Hambleton S, Bredius R, Notarangelo LD, van der Burg M, Kalinke U, Villa A, Benvenuti F.
J Exp Med. 2013 Feb 11;210(2):355-74. doi: 10.1084/jem.20120363. Epub 2013 Jan 21.
Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome.
Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabéra C, Moshous D, Neven B, Picard C, de Saint-Basile G, Cavazzana-Calvo M, Blanche S, Fischer A.
Blood. 2013 Feb 28;121(9):1510-6. doi: 10.1182/blood-2012-08-448118. Epub 2012 Dec 20.
A novel Wiskott-Aldrich syndrome protein mutation in an infant with thrombotic thrombocytopenic purpura.
Kawasaki Y, Toyoda H, Otsuki S, Iwasa T, Iwamoto S, Azuma E, Itoh-Habe N, Wada H, Fujimura Y, Morio T, Imai K, Mitsuiki N, Ohara O, Komada Y.
Eur J Haematol. 2013 Feb;90(2):164-8. doi: 10.1111/ejh.12057. Epub 2013 Jan 7.
Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions.
Rajput C, Kini V, Smith M, Yazbeck P, Chavez A, Schmidt T, Zhang W, Knezevic N, Komarova Y, Mehta D.
J Biol Chem. 2013 Feb 8;288(6):4241-50. doi: 10.1074/jbc.M112.440396. Epub 2012 Dec 4.
Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
Lang PA, Shaabani N, Borkens S, Honke N, Scheu S, Booth S, Brenner D, Meryk A, Barthuber C, Recher M, Mak TW, Ohashi PS, Häussinger D, Griffiths GM, Thrasher AJ, Bouma G, Lang KS.
J Allergy Clin Immunol. 2013 Mar;131(3):815-24. doi: 10.1016/j.jaci.2012.08.050. Epub 2012 Nov 6.
Clinical and molecular characterization of Thai patients with Wiskott-Aldrich syndrome.
Amarinthnukrowh P, Ittiporn S, Tongkobpetch S, Chatchatee P, Sosothikul D, Shotelersuk V, Suphapeetiporn K.
Scand J Immunol. 2013 Jan;77(1):69-74. doi: 10.1111/sji.12004.
Interactions of isolated C-terminal fragments of neural Wiskott-Aldrich syndrome protein (N-WASP) with actin and Arp2/3 complex.
Gaucher JF, Maugé C, Didry D, Guichard B, Renault L, Carlier MF.
J Biol Chem. 2012 Oct 5;287(41):34646-59. doi: 10.1074/jbc.M112.394361. Epub 2012 Jul 30.
Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1.
Lafouresse F, Cotta-de-Almeida V, Malet-Engra G, Galy A, Valitutti S, Dupré L.
Immunology. 2012 Oct;137(2):183-96. doi: 10.1111/j.1365-2567.2012.03620.x.
Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia.
Sano H, Kobayashi R, Suzuki D, Yasuda K, Nakanishi M, Nagashima T, Yamada M, Kobayashi K.
Int J Hematol. 2012 Aug;96(2):279-83. doi: 10.1007/s12185-012-1130-x. Epub 2012 Jun 27.
Molecular basis of Wiskott-Aldrich syndrome in patients from India.
David S, Jayandharan GR, Abraham A, Jacob RR, Devi GS, Patkar N, Shaji RV, Nair SC, Viswabandya A, Ahmed R, George B, Mathews V, Chandy M, Srivastava A.
Eur J Haematol. 2012 Oct;89(4):356-60. doi: 10.1111/j.1600-0609.2012.01818.x. Epub 2012 Jul 14. No abstract available.
Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.
Serrano-Pertierra E, Cernuda-Morollón E, López-Larrea C.
Eur J Immunol. 2012 Aug;42(8):2142-51. doi: 10.1002/eji.201142070.
Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India.
Suri D, Singh S, Rawat A, Gupta A, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O, Bilhou-Nabera C, Proust A, Ahluwalia J, Dogra S, Saikia B, Minz RW, Sehgal S.
Asian Pac J Allergy Immunol. 2012 Mar;30(1):71-8.
Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.
Astrakhan A, Sather BD, Ryu BY, Khim S, Singh S, Humblet-Baron S, Ochs HD, Miao CH, Rawlings DJ.
Blood. 2012 May 10;119(19):4395-407. doi: 10.1182/blood-2011-03-340711. Epub 2012 Mar 19.
Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
Ariga T.
Allergol Int. 2012 Jun;61(2):183-9. doi: 10.2332/allergolint.11-RAI-0412. Epub 2012 Feb 25. Review.
Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T, Adriani M, Jagadeesh GJ, Paine A, Candotti F.
Mol Ther. 2012 Jun;20(6):1270-9. doi: 10.1038/mt.2011.282. Epub 2012 Jan 3.
Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.
Shimizu M, Nikolov NP, Ueno K, Ohta K, Siegel RM, Yachie A, Candotti F.
Clin Immunol. 2012 Feb;142(2):160-6. doi: 10.1016/j.clim.2011.10.001. Epub 2011 Oct 19.
Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.
Coccia P, Mastrangelo S, Ruggiero A, Scalzone M, Rosolen A, Maurizi P, Riccardi R.
Pediatr Blood Cancer. 2012 Aug;59(2):318-9. doi: 10.1002/pbc.23393. Epub 2011 Nov 2.
IVS6+5G>A found in Wiskott-Aldrich syndrome and X-linked thrombocytopenia in a Korean family.
Yoon SH, Cho T, Kim HJ, Kim SY, Ko JH, Baek HS, Lee HJ, Lee CH.
Pediatr Blood Cancer. 2012 Feb;58(2):297-9. doi: 10.1002/pbc.23377. Epub 2011 Oct 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on